EI
CRDF icon

Ellevest Inc’s Cardiff Oncology CRDF Stock Holding History

Ellevest Inc’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4
Closed – – 1458
2021
Q3 		$0 Buy
+4
New +$25 ﹤0.01% 1433

Other funds holding CRDF

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ellevest Inc's CRDF Position: Q4 2021 in Review

Ellevest Inc sold out of Cardiff Oncology (CRDF) in Q4 2021, closing a stake of 4 shares.

Ellevest Inc first reported a position in CRDF in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 87 funds tracked by Wall St. Rank hold CRDF as of Q4 2021.

  • Ellevest Inc reported no remaining Cardiff Oncology position as of Q4 2021 after selling out during the quarter.
  • Ellevest Inc sold 4 Cardiff Oncology shares in Q4 2021.
  • Ellevest Inc first reported a position in Cardiff Oncology in Q3 2021 and held it in 1 quarter.
  • Ellevest Inc's Cardiff Oncology position peaked at $0 in Q3 2021.
  • 87 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2021.

Based on Ellevest Inc's 13F filing for Q4 2021, filed 24 Jan 2022.